Effect of low-dose spironolactone on resistant hypertension in type 2 diabetes mellitus: a randomized controlled trial in a sub-Saharan African population

BACKGROUND: Low-dose spironolactone has been proven to be effective for resistant hypertension in the general population, but this has yet to be confirmed in type 2 diabetic (T2DM) patients. We assessed the efficacy of a low-dose spironolactone on resistant hypertension in a sub-Saharan African popu...

Descripción completa

Detalles Bibliográficos
Autores principales: Djoumessi, Romance Nguetse, Noubiap, Jean Jacques N., Kaze, Francois Folefack, Essouma, Mickael, Menanga, Alain Patrick, Kengne, Andre Pascal, Mbanya, Jean Claude, Sobngwi, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804513/
https://www.ncbi.nlm.nih.gov/pubmed/27007793
http://dx.doi.org/10.1186/s13104-016-1987-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804513/
https://www.ncbi.nlm.nih.gov/pubmed/27007793
http://dx.doi.org/10.1186/s13104-016-1987-5

Ejemplares similares